An omicron-specific vaccine will be ready in March as manufacturing activities are in top gear, Alber Bourla, Pfizer CEO said on Monday. He said despite uncertainties around the need for an omicron vaccine or how it would be used, the biotechnology company will have some doses ready on urgent dem
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp